Envestnet Asset Management Inc Beam Therapeutics Inc. Transaction History

Envestnet Asset Management Inc

$324 Billion
Q3 2025

A detailed history of Envestnet Asset Management Inc transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 39,267 shares of BEAM stock, worth $864,659. This represents 0.0% of its overall portfolio holdings.

Number of Shares

39,267

Previous 34,848 12.68%

Holding current value

$864,659

Previous $592,000 60.98%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 04, 2025	BUY	$16.01 - $25.1 $70,748 - $110,916	4,419 Added 12.68%	39,267 $953,000
Q2 2025 Jul 31, 2025	BUY	$14.54 - $20.24 $75,113 - $104,559	5,166 Added 17.4%	34,848 $592,000
Q1 2025 Apr 29, 2025	SELL	$19.53 - $34.09 $15,331 - $26,760	-785 Reduced 2.58%	29,682 $579,000
Q4 2024 Feb 12, 2025	BUY	$21.55 - $30.35 $49,478 - $69,683	2,296 Added 8.15%	30,467 $755,000
Q3 2024 Nov 06, 2024	BUY	$22.57 - $33.14 $172,276 - $252,957	7,633 Added 37.17%	28,171 $690,000

Q2 2024 Aug 08, 2024	SELL	$21.22 - $32.66 $33,994 - $52,321	-1,602 Reduced 7.24%	20,538 $481,000
Q1 2024 May 13, 2024	BUY	$23.46 - $45.07 $2,275 - $4,371	97 Added 0.44%	22,140 $731,000
Q4 2023 Feb 13, 2024	BUY	$17.69 - $30.76 $210,511 - $366,044	11,900 Added 117.32%	22,043 $600,000
Q3 2023 Nov 13, 2023	SELL	$23.01 - $32.46 $117,304 - $165,481	-5,098 Reduced 33.45%	10,143 $243,000
Q2 2023 Aug 04, 2023	BUY	$29.32 - $35.99 $69,693 - $85,548	2,377 Added 18.48%	15,241 $486,000
Q1 2023 May 11, 2023	BUY	$30.15 - $48.79 $158,106 - $255,854	5,244 Added 68.82%	12,864 $393,000
Q4 2022 Feb 07, 2023	BUY	$36.73 - $51.6 $74,929 - $105,264	2,040 Added 36.56%	7,620 $298,000
Q3 2022 Nov 10, 2022	BUY	$39.79 - $70.31 $222,028 - $392,329	5,580 New	5,580 $266,000
Q2 2022 Aug 03, 2022	SELL	$29.86 - $62.36 $106,062 - $221,502	-3,552 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$53.73 - $82.16 $190,848 - $291,832	3,552 New	3,552 $204,000
Q4 2021 Feb 04, 2022	SELL	$68.02 - $99.06 $336,699 - $490,347	-4,950 Closed	0 $0
Q3 2021 Oct 07, 2021	BUY	$84.37 - $133.6 $417,631 - $661,320	4,950 New	4,950 $431,000

Others Institutions Holding BEAM

# of Institutions

249

Shares Held

95M

Call Options Held

888K

Put Options Held

549K

View Full List

About Beam Therapeutics Inc.

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.55B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

More about BEAM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account

Envestnet Asset Management Inc Beam Therapeutics Inc. Transaction History